Registered entities
Heparegenix Gmbh
Reg. No. HRB772644Germany
Innovation
8 patent families (6 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 1,238 times.
| Year | Filings |
|---|---|
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 6 |
| 2022 | 4 |
| 2023 | 6 |
| 2024 | 4 |
| 2025 | 6 |
Social engagement
Social engagement: 1.2K social following, 9 posts in the last 12 months — below the industry typical range.
Investor mix
11 investors on record; lead investors include Boehringer Ingelheim Venture Fund, Novo Holdings, HTGF, Coparion.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 55% |
| Other / undisclosed | 5 | 45% |
Recent activity
23 Feb 2026
Event
Inaugural Colorectal Liver Metastasis Consensus Conference
13 Jan 2026
Leadership hire
Senior Medical Director
10 Nov 2025
Event
LSX Investival Showcase and Jefferies Global Healthcare Conference